MedTrace Logo

Safety and Efficacy of Oral Bovine Lactoferrin

NCT04094597 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2019-09-19

No results posted yet for this study

Summary

Oral lactoferrin versus Placebo will be given to preterm neonates

Conditions

  • Neonatal SEPSIS

Interventions

DRUG

Lactoferrin

lactoferrin is given orally in comparsion to placebp

DRUG

Placebos

placebp is given in 2 ml saline

Sponsors & Collaborators

  • Kasr El Aini Hospital

    collaborator OTHER

  • Cairo University

    lead OTHER

Principal Investigators

  • ayman zaher, bachelor · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
7 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-12-28
Completion
2019-03-02

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04094597 on ClinicalTrials.gov